XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements Of Cash Flows - USD ($)
 9 Months Ended
Nov. 27, 2020
Nov. 22, 2019
OPERATING ACTIVITIES    
Net income $ 19,500,000 $ 133,200,000
Depreciation and amortization 64,100,000 62,900,000
Goodwill, Impairment Loss 17,600,000 0
Restructuring Charges 27,000,000.0 0
Increase (Decrease) in Deferred Income Taxes 17,900,000 13,900,000
Non-cash stock compensation 11,900,000 14,300,000
Equity in income of unconsolidated affiliates (6,700,000) (9,900,000)
Dividends received from unconsolidated affiliates 5,200,000 8,800,000
Other (12,400,000) (3,600,000)
Changes in operating assets and liabilities net of acquisitions:    
Accounts receivable 105,200,000 (60,800,000)
Inventories (16,400,000) (25,200,000)
Other assets (22,900,000) 12,100,000
Accounts payable (47,000,000.0) 41,600,000
Employee compensation liabilities (130,500,000) (8,800,000)
Employee benefit obligations (25,200,000) (5,700,000)
contract with customer, increases in liability due to deposits received 30,400,000 6,200,000
Accrued Liabilities and Other Operating Liabilities (500,000) 39,800,000
Net cash provided by operating activities 37,200,000 218,800,000
INVESTING ACTIVITIES    
Capital expenditures (32,100,000) (49,100,000)
Proceeds from Sale of Property, Plant, and Equipment 7,300,000 1,000,000.0
Other 7,000,000.0 2,000,000.0
Net cash provided by (used in) investing activities (17,800,000) (46,100,000)
FINANCING ACTIVITIES    
Dividends paid (31,800,000) (51,900,000)
Common stock repurchases (42,700,000) (8,700,000)
Proceeds from Lines of Credit 250,000,000.0 0
Repayments of Lines of Credit (250,000,000.0) 0
Proceeds from (Payments for) Other Financing Activities (2,100,000) (3,500,000)
Net cash used in financing activities (76,600,000) (64,100,000)
Effect of exchange rate changes on cash and cash equivalents 1,800,000 (800,000)
Net increase (decrease) in cash, cash equivalents and restricted cash (55,400,000) 107,800,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [1] 547,100,000 264,800,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [2] 491,700,000 372,600,000
Restricted Cash 7,300,000 $ 4,900,000
Fair Value, Recurring [Member]    
Restricted Cash $ 7,300,000  
[1] These amounts include restricted cash of $6.1 and $3.5 as of February 28, 2020 and February 22, 2019, respectively.
[2] These amounts include restricted cash of $7.3 and $4.9 as of November 27, 2020 and November 22, 2019, respectively.Restricted cash primarily represents funds held in escrow for potential future workers’ compensation and product liability claims.  Restricted cash is included as part of Other assets in the Condensed Consolidated Balance Sheets.